跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SERBEHISTIN betahistine dihydrochloride 16 mg tablets blister packs - TGA Drug Approval Details
Approvals
/
TGA
/
SERBEHISTIN betahistine dihydrochloride 16 mg tablets blister packs
Approved
STANDARD
SERBEHISTIN betahistine dihydrochloride 16 mg tablets blister packs
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
8d534669009bf8d7
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
8d534669009bf8d7
Product Name
SERBEHISTIN betahistine dihydrochloride 16 mg tablets blister packs
Artg Id
212083
Artg Name
SERBEHISTIN betahistine dihydrochloride 16 mg tablets blister packs
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2014-08-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
8d534669009bf8d7
Type
Standard
Back to TGA Approvals
